Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 356290, 13 pages
http://dx.doi.org/10.1155/2014/356290
Research Article

Ethanolic Extract of Butea monosperma Leaves Elevate Blood Insulin Level in Type 2 Diabetic Rats, Stimulate Insulin Secretion in Isolated Rat Islets, and Enhance Hepatic Glycogen Formation

Department of Pharmacy, North South University, Plot 15, Block B, Bashundhara R/A, Dhaka 1229, Bangladesh

Received 20 October 2013; Revised 6 February 2014; Accepted 25 February 2014; Published 31 March 2014

Academic Editor: Siew Hua Gan

Copyright © 2014 Mehdi Bin Samad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Cockram, “The epidemiology of diabetes mellitus in the Asia-Pacific region,” Hong Kong Medical Journal, vol. 6, no. 1, pp. 43–52, 2000. View at Google Scholar · View at Scopus
  2. EURODIAB ACE Study Group, “Variation and trends in incidence of childhood diabetes in Europe,” The Lancet, vol. 355, no. 9207, pp. 873–876, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Aschner, “Diabetes trends in Latin America,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 3, pp. S27–S31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Fagot-Campagna, D. J. Pettitt, M. M. Engelgau et al., “Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective,” Journal of Pediatrics, vol. 136, no. 5, pp. 664–672, 2000. View at Google Scholar · View at Scopus
  5. E. S. Huang, A. Basu, M. O'Grady, and J. C. Capretta, “Projecting the future diabetes population size and related costs for the U.S,” Diabetes Care, vol. 32, no. 12, pp. 2225–2229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Yach, D. Stuckler, and K. D. Brownell, “Epidemiologic and economic consequences of the global epidemics of obesity and diabetes,” World, vol. 5, no. 9.4, p. 8, 2006. View at Google Scholar
  7. F. B. Hu, “Globalization of diabetes: the role of diet, lifestyle, and genes,” Diabetes Care, vol. 34, no. 6, pp. 1249–1257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Turner, C. A. Cull, V. Frighi, and R. R. Holman, “Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49),” Journal of the American Medical Association, vol. 281, no. 21, pp. 2005–2012, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Krentz and C. J. Bailey, “Oral antidiabetic agents: current role in type 2 diabetes mellitus,” Drugs, vol. 65, no. 3, pp. 385–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Google Scholar · View at Scopus
  11. E. Ernst, “Prevalence of use of complementary/alternative medicine: a systematic review,” Bulletin of the World Health Organization, vol. 78, no. 2, pp. 252–257, 2000. View at Google Scholar · View at Scopus
  12. E. Ernst, “The role of complementary and alternative medicine,” British Medical Journal, vol. 321, no. 7269, pp. 1133–1135, 2000. View at Google Scholar · View at Scopus
  13. R. Somani, S. Kasture, and A. K. Singhai, “Antidiabetic potential of Butea monosperma in rats,” Fitoterapia, vol. 77, no. 2, pp. 86–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Bavarva and A. V. R. L. Narasimhacharya, “Preliminary study on antihyperglycemic and antihyperlipaemic effects of Butea monosperma in NIDDM rats,” Fitoterapia, vol. 79, no. 5, pp. 328–331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Sharma and V. Garg, “Antihyperglycemic and antioxidative potential of hydroalcoholic extract of butea monosperma lam flowers in alloxan-induced diabetic mice,” Indian Journal of Experimental Biology, vol. 47, no. 7, pp. 571–576, 2009. View at Google Scholar · View at Scopus
  16. S. Panda, M. Jafri, A. Kar, and B. K. Meheta, “Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma,” Fitoterapia, vol. 80, no. 2, pp. 123–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Sehrawat and S. Sultana, “Chemoprevention by Butea monosperma of hepatic carcinogenesis and oxidative damage in male wistar rats,” Asian Pacific Journal of Cancer Prevention, vol. 7, no. 1, pp. 140–148, 2006. View at Google Scholar · View at Scopus
  18. N. Sharma and V. Garg, “Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice,” Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 99–105, 2009. View at Google Scholar · View at Scopus
  19. A. M. Gallagher, P. R. Flatt, G. Duffy, and Y. H. A. Abdel-Wahab, “The effects of traditional antidiabetic plants on in vitro glucose diffusion,” Nutrition Research, vol. 23, no. 3, pp. 413–424, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Bayne, “Revised guide for the care and use of laboratory animals available. American physiological society,” The Physiologist, vol. 39, no. 4, pp. 199–211, 1996. View at Google Scholar · View at Scopus
  21. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Moniruzzaman, B. Rokeya, S. Ahmed, A. Bhowmik, I. Khalil, and S. H. Gan, “In vitro antioxidant effects of Aloe barbadensis Miller extracts and the potential role of these extracts as antidiabetic and antilipidemic agents on streptozotocin-induced type 2 diabetic model rats,” Molecules, vol. 17, no. 11, pp. 12851–12867, 2012. View at Google Scholar
  23. P. Trinder, “Enzymatic Colorimetric method for estimation of Glucose Test (GOD-PAP method), uric acid and phosohlipids,” Annals of Clinical Biochemistry, vol. 6, p. 25, 1969. View at Google Scholar
  24. S. Moskalewski, “Studies on the culture and transplantation of isolated islets of langerhans of the guinea pig,” Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen C, vol. 72, no. 2, pp. 157–171, 1969. View at Google Scholar · View at Scopus
  25. J. van der Vies, “Two methods for the determination of glycogen in liver,” The Biochemical Journal, vol. 57, no. 3, pp. 410–416, 1954. View at Google Scholar · View at Scopus
  26. J. V. Swintosky and E. Pogonowska-Wala, “The in-situ rat gut technique,” Pharmacy International, vol. 3, no. 5, pp. 163–167, 1982. View at Google Scholar · View at Scopus
  27. J. M. A. Hannan, L. Ali, B. Rokeya et al., “Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action,” British Journal of Nutrition, vol. 97, no. 3, pp. 514–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Goto, K. Yamada, T. Ohyama, T. Matsuo, H. Odaka, and H. Ikeda, “An α-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans,” Diabetes Research and Clinical Practice, vol. 28, no. 2, pp. 81–87, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Chatterjee, Handbook of Laboratory Mice and Rats, Jadavpur University, Kolkata, India, 1993.
  30. C.-F. Chau, Y.-L. Huang, and M.-H. Lee, “In vitro hypoglycemic effects of different insoluble fiber-rich fractions prepared from the peel of Citrus sinensis L. cv. Liucheng,” Journal of Agricultural and Food Chemistry, vol. 51, no. 22, pp. 6623–6626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Ou, K.-C. Kwok, Y. Li, and L. Fu, “In vitro study of possible role of dietary fiber in lowering postprandial serum glucose,” Journal of Agricultural and Food Chemistry, vol. 49, no. 2, pp. 1026–1029, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Klein, “Hyperglycemia and microvascular and macrovascular disease in diabetes,” Diabetes Care, vol. 18, no. 2, pp. 258–268, 1995. View at Google Scholar · View at Scopus
  34. J. R. Williamson, K. Chang, M. Frangos et al., “Hyperglycemic pseudohypoxia and diabetic complications,” Diabetes, vol. 42, no. 6, pp. 801–813, 1993. View at Google Scholar · View at Scopus
  35. R. W. Nesto, “Correlation between cardiovascular disease and diabetes mellitus: current concepts,” The American Journal of Medicine, vol. 116, no. 5, pp. 11–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. W. A. Hsueh, C. J. Lyon, and M. J. Quiñones, “Insulin resistance and the endothelium,” The American Journal of Medicine, vol. 117, no. 2, pp. 109–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. H. N. Ginsberg, “Insulin resistance and cardiovascular disease,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 453–458, 2000. View at Google Scholar · View at Scopus
  38. R. D. Siegel, A. Cupples, E. J. Schaefer, and P. W. F. Wilson, “Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study,” Metabolism: Clinical and Experimental, vol. 45, no. 10, pp. 1267–1272, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Krauss, “Lipids and lipoproteins in patients with type 2 diabetes,” Diabetes Care, vol. 27, no. 6, pp. 1496–1504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Haffner, “Dyslipidemia management in adults with diabetes,” Diabetes Care, vol. 27, p. S68, 2004. View at Google Scholar
  41. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori, “Spontaneous long-term hyperglycemic rat with diabetic complications: otsuka Long-Evans Tokushima Fatty (OLETF) strain,” Diabetes, vol. 41, no. 11, pp. 1422–1428, 1992. View at Google Scholar · View at Scopus
  42. S. Schneider, P. J. Feilen, M. Schreckenberger et al., “In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans,” Experimental and Clinical Endocrinology and Diabetes, vol. 113, no. 7, pp. 388–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Guiot, J.-B. Henquin, and J. Rahier, “Effects of glibenclamide on pancreatic β-cell proliferation in vivo,” European Journal of Pharmacology, vol. 261, no. 1-2, pp. 157–161, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. D. J. A. Jenkins, T. M. S. Wolever, and A. R. Leeds, “Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity,” British Medical Journal, vol. 1, no. 6124, pp. 1392–1394, 1978. View at Google Scholar · View at Scopus
  45. P.-H. Groop, A. Aro, S. Stenman, and L. Groop, “Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus,” American Journal of Clinical Nutrition, vol. 58, no. 4, pp. 513–518, 1993. View at Google Scholar · View at Scopus
  46. C. A. Edwards, I. T. Johnson, and N. W. Read, “Do viscous polysaccharides slow absorption by inhibiting diffusion or convection?” European Journal of Clinical Nutrition, vol. 42, no. 4, pp. 307–312, 1988. View at Google Scholar · View at Scopus
  47. D. P. Burkitt, A. R. Walker, and N. S. Painter, “Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease,” The Lancet, vol. 2, no. 7792, pp. 1408–1412, 1972. View at Google Scholar · View at Scopus
  48. A. M. Holgate and N. W. Read, “Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose,” Digestive Diseases and Sciences, vol. 28, no. 9, pp. 812–819, 1983. View at Google Scholar · View at Scopus
  49. J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso, “Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial,” The Lancet, vol. 359, no. 9323, pp. 2072–2077, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso, “Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial,” Journal of the American Medical Association, vol. 290, no. 4, pp. 486–494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. W. T. Garvey, J. M. Olefsky, and J. Griffin, “The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus,” Diabetes, vol. 34, no. 3, pp. 222–234, 1985. View at Google Scholar · View at Scopus
  52. R. E. Pratley and C. Weyer, “The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus,” Diabetologia, vol. 44, no. 8, pp. 929–945, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. DeFronzo, R. Gunnarsson, and O. Bjorkman, “Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus,” Journal of Clinical Investigation, vol. 76, no. 1, pp. 149–155, 1985. View at Google Scholar · View at Scopus